Drug
Gabapentin Enacarbil
Gabapentin Enacarbil: highest development phase Post-Market, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| Gabapentin enacarbil NCT01981941 | Post-Market | Restless Legs Syndrome (RLS) |
Latest
No recent events.
Follow Gabapentin Enacarbil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.